MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer

MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer

Abstract Background Colon cancer is a most common malignant cancer in digestive system, and it is prone to develop resistance to the commonly used chemotherapy drugs, leading to local recurrence and metastasis. Paris saponin VII (PSVII) could not only inhibit the proliferation of colon cancer cells...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shaobo Bai, Yang Sun, Ying Cheng, Weiliang Ye, Chenchao Jiang, Miao Liu, Qifeng Ji, Bangle Zhang, Qibing Mei, Daozhou Liu, Siyuan Zhou
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Paris saponin VII
Modified citrus pectin
Drug-resistant colon cancer
Colon cancer targeting drug delivery system
Calcium phosphate nanoparticles
Biotechnology
TP248.13-248.65
Medical technology
R855-855.5
Acceso en línea:https://doaj.org/article/dcf8c67b8de749f48595d7b0a10db641
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/dcf8c67b8de749f48595d7b0a10db641

Ejemplares similares